Comparison of Interpretation between Pyrosequencing and Xpert MTB/RIF Assay in Multidrug-Resistant Tuberculosis

Comparison of Interpretation between Pyrosequencing and Xpert MTB/RIF Assay in Multidrug-Resistant Tuberculosis

Indonesia is one of the countries with the highest multidrug-resistant tuberculosis cases in the world. Rapid molecular test using the Xpert MTB/RIF assay is one of the detection methods for MDR-TB. Early detection of MDR-TB is crucial for early initiation of treatment. However, Xpert MTB/RIF assay...

Full description

Bibliographic Details
Main Authors:	Linda Choerunnisa, Coriejati Rita, Anna Tjandrawati, Lidya Chaidir, Ida Parwati
Format:	Article
Language:	English
Published:	Universitas Padjajaran 2020-12-01
Series:	Majalah Kedokteran Bandung
Subjects:	multidrug-resistant tuberculosis, pyrosequencing, xpert mtb/rif assay
Online Access:	http://journal.fk.unpad.ac.id/index.php/mkb/article/view/2141

Similar Items

Evaluation of Xpert MTB/RIF assay performance in the diagnosis of abdominal tuberculosis
by: Suraj Kumar, et al.
Published: (2017-04-01)

Xpert MTB/RIF Ultra assay for the detection of Mycobacterium tuberculosis in people with negative conventional Xpert MTB/RIF but chest imaging suggestive of tuberculosis in Dhaka, Bangladesh
by: Samanta Biswas, et al.
Published: (2022-01-01)

Diagnostic Performance of Xpert MTB/RIF Ultra Compared with Predecessor Test, Xpert MTB/RIF, in a Low TB Incidence Setting: a Retrospective Service Evaluation
by: Mary Mansfield, et al.
Published: (2022-06-01)

Use of Xpert MTB/RIF for diagnosis of pediatric tuberculosis in Indonesia
by: Rina Triasih, et al.
Published: (2020-07-01)

Implementation of the Xpert MTB/RIF assay for tuberculosis in Mongolia: a qualitative exploration of barriers and enablers
by: Nicole L. Rendell, et al.
Published: (2017-07-01)

An evaluation of false-positive rifampicin resistance on the Xpert MTB/RIF
by: Yeliz Tanriverdi Cayci, et al.

Xpert MTB/RIF Ultra Assay Using Stool: an Effective Solution for Bacilli Identification from Adult Pulmonary Tuberculosis Suspects without Expectorated Sputum
by: Xia Yu, et al.
Published: (2023-08-01)

The Magnitude of MTB and Rifampicin Resistance MTB Using Xpert-MTB/RIF Assay Among Tuberculosis Suspected Patients in Gedeo Zone, Southern Ethiopia
by: Diriba K, et al.
Published: (2021-09-01)

Diagnostic utility of GeneXpert MTB/RIF assay versus conventional methods for diagnosis of pulmonary and extra-pulmonary tuberculosis
by: Asmaa Mohammed Elbrolosy, et al.
Published: (2021-05-01)

Xpert MTB/RIF Ultra outperformed the Xpert assay in tuberculosis lymphadenitis diagnosis: a prospective head-to-head cohort study
by: Xia Yu, et al.
Published: (2022-09-01)

Performance of Xpert/MTB/RIF assay for childhood pulmonary tuberculosis among HIV negative children with real world evidence in China
by: Lu Xia, et al.
Published: (2020-11-01)

Evaluation of Xpert MTB/RIF and MODS assay for the diagnosis of pediatric tuberculosis
by: Nhu Nguyen Thi Quynh, et al.
Published: (2013-01-01)

High prevalence of multidrug-resistant tuberculosis among patients with rifampicin resistance using GeneXpert Mycobacterium tuberculosis/rifampicin in Ghana
by: Justice K Boakye-Appiah, et al.
Published: (2016-01-01)

The transition to Xpert MTB/RIF ultra: diagnostic accuracy for pulmonary tuberculosis in Kampala, Uganda
by: A. Andama, et al.
Published: (2021-01-01)

Utility of Xpert MTB/RIF Assay for Diagnosis of Pediatric Tuberculosis Under Programmatic Conditions in India
by: Rakesh Yadav, et al.
Published: (2020-01-01)

Accuracy of Nanopore Sequencing as a Diagnostic Assay for Pulmonary Tuberculosis versus Smear, Culture and Xpert MTB/RIF: A Head-to-Head Comparison
by: Juan Yang, et al.
Published: (2023-09-01)

Evaluation of GeneXpert MTB/RIF for determination of rifampicin resistance among new tuberculosis cases in west and northwest Iran
by: S. Atashi, et al.
Published: (2017-09-01)

A feasibility study of the Xpert MTB/RIF test at the peripheral level laboratory in China
by: Xichao Ou, et al.
Published: (2015-02-01)

Study of diagnostic utility of Xpert MTB/Rif test on pleural fluid in the evaluation of patients presenting with Pleural Tuberculosis in Nepal
by: Deebya Raj Mishra, et al.
Published: (2022-01-01)

Cost-effectiveness of Xpert®MTB/RIF in the diagnosis of tuberculosis: pragmatic study
by: Suely Conceição Alves da Silva, et al.
Published: (2021-02-01)

Diagnostic performance of GeneXpert MTB/RIF in detecting MTB in smear-negative presumptive TB patients
by: Raksha Rimal, et al.
Published: (2022-04-01)

Xpert MTB/RIF assay did not improve diagnosis of pulmonary tuberculosis among child contacts in Rwanda
by: Francine Mwayuma Birungi, et al.
Published: (2018-05-01)

Pyrosequencing to resolve discrepant Xpert MTB/RIF and Mycobacterial Growth Indicator Tube 960
by: Kanchan Ajbani, et al.
Published: (2018-01-01)

Validitas Metode Polymerase Chain Reaction GeneXpert MTB/RIF pada Bahan Pemeriksaan Sputum untuk Mendiagnosis Multidrug Resistant Tuberculosis
by: Nurlina Sirait, et al.
Published: (2013-12-01)

Xpert MTB/RIF assay for diagnosis of extrapulmonary tuberculosis in children: a systematic review and meta-analysis
by: Young Seok Seo, et al.
Published: (2020-01-01)

Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, Russia
by: Julia V. Ershova, et al.
Published: (2020-07-01)

Difficulties with the implemented xpert MTB/RIF for determining diagnosis of pulmonary and extrapulmonary tuberculosis in adults and children
by: Ni Made Mertaniasih, et al.
Published: (2020-05-01)

Xpert MTB/RIF assay for the diagnosis of rifampicin resistance in different regions: a meta-analysis
by: Kaican Zong, et al.
Published: (2019-08-01)

Diagnostic value of tNGS vs Xpert MTB/RIF in childhood TB
by: Huiwen Zheng, et al.
Published: (2024-01-01)

Diagnostic accuracy of GeneXpert MTB/RIF in musculoskeletal tuberculosis: High sensitivity in tissue samples of HIV-infected and HIV-uninfected patients
by: M Held, et al.
Published: (2017-10-01)

Evaluation of Xpert MTB/RIF Assay on Stool Samples for the Diagnosis of Pulmonary Tuberculosis among the Pediatric Population
by: Sangitha Jayagandan, et al.
Published: (2023-09-01)

The value of Xpert MTB/RIF assay of urine samples in the early diagnosis of smear-negative urinary tuberculosis
by: Yachun Wang, et al.
Published: (2022-12-01)

Does Xpert® MTB/RIF assay give rifampicin resistance results without identified mutation? Review of cases from Addis Ababa, Ethiopia
by: Ayinalem Alemu, et al.
Published: (2020-01-01)

XPERT MTB/RIF TEST FOR THE DIAGNOSIS OF TUBERCULOSIS AND RIFAMPICIN RESISTANCE: RESULTS OF ITS INTRODUCTION IN THE KYRGYZ REPUBLIC
by: A. D. Adambekova, et al.
Published: (2014-01-01)

Rolling out Xpert MTB/RIF® for tuberculosis detection in HIV-positive populations: An opportunity for systems strengthening
by: Ishani Pathmanathan, et al.
Published: (2017-03-01)

Role of empiric treatment in hospitalized patients with Xpert MTB/RIF-negative presumptive pulmonary tuberculosis: A prospective cohort study
by: Wakjira Kebede, et al.
Published: (2020-08-01)

Construction and application of a heterogeneous quality control library for the Xpert MTB/RIF assay in tuberculosis diagnosis
by: Zehao Guan, et al.
Published: (2023-03-01)

Xpert MTB/RIF Assay for the Diagnosis of Lymph Node Tuberculosis in Children: A Systematic Review and Meta-Analysis
by: Hao-Kai Chen, et al.
Published: (2022-08-01)

The New Xpert MTB/RIF Ultra: Improving Detection of <italic toggle="yes">Mycobacterium tuberculosis</italic> and Resistance to Rifampin in an Assay Suitable for Point-of-Care Testing
by: Soumitesh Chakravorty, et al.
Published: (2017-09-01)

Apport du Test Xpert MTB/RIF dans le diagnostic et le traitement de la tuberculose.
by: HE Hassan, et al.
Published: (2021-06-01)